BioCryst Pharma (BCRX) Commences $55M Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 8.07 -0.29 (3.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.36 | 52 Week High | $10.98 | |||
| Open | $8.22 | 52 Week Low | $1.63 | |||
| Day High | $8.32 | P/E | N/A | |||
| Day Low | $8.06 | EPS | $-0.68 | |||
| Volume | 3,042,075 | |||||
